Product Program year 2025 Source: CMS Open Payments

Procalcitonin

Drug Infectious Disease

Open in the dashboard

General payments

$45,836

64 payments

Research payments

$0

0 payments

Through program year 2025, $45,836 in general payments and $0 in research payments were reported against Procalcitonin (Infectious Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $1,993 13
2020 General $43,844 51

Breakdown

Who paid General payments · program years 2020–2025
  1. Fisher Scientific Company L.L.C. $45,836 64 payments
Top recipients General payments · program year 2025
  1. Sarah Weaver Obstetrics & Gynecology · Orlando, FL $266 13% · 3 payments
  2. Daniela Meshkat Obstetrics & Gynecology · San Diego, CA $188 9% · 1 payment
  3. Rahele Mazarei Obstetrics & Gynecology · Vista, CA $188 9% · 1 payment
  4. Yvonne Gollin Obstetrics & Gynecology · Loma Linda, CA $188 9% · 1 payment
  5. Tevy Tith Maternal & Fetal Medicine · San Diego, CA $188 9% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $832 42% · 4 practitioners
  2. Maternal & Fetal Medicine Obstetrics & Gynecology $754 38% · 4 practitioners
  3. Surgery $136 7% · 1 practitioner
  4. Pediatrics $136 7% · 1 practitioner
  5. Nurse Practitioner, Family Nurse Practitioner $136 7% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $1,319 66% · 7 recipients
  2. New York $271 14% · 2 recipients
  3. Florida $266 13% · 1 recipient
  4. Missouri $136 7% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

64 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record